Literature DB >> 16271649

Preventing chronic diseases: taking stepwise action.

Joanne E Epping-Jordan1, Gauden Galea, Colin Tukuitonga, Robert Beaglehole.   

Abstract

The scientific knowledge to achieve a new global goal for the prevention of chronic diseases--a 2% yearly reduction in rates of death from chronic disease over and above projected declines during the next 10 years--already exists. However, many low-income and middle-income countries must deal with the practical realities of limited resources and a double burden of infectious and chronic diseases. This paper presents a novel planning framework that can be used in these contexts: the stepwise framework for preventing chronic diseases. The framework offers a flexible and practical public health approach to assist ministries of health in balancing diverse needs and priorities while implementing evidence-based interventions such as those recommended by the WHO Framework Convention on Tobacco Control and the WHO Global Strategy on Diet, Physical Activity and Health. Countries such as Indonesia, the Philippines, Tonga, and Vietnam have applied the stepwise planning framework: their experiences illustrate how the stepwise approach has general applicability to solving chronic disease problems without sacrificing specificity for any particular country.

Entities:  

Mesh:

Year:  2005        PMID: 16271649     DOI: 10.1016/S0140-6736(05)67342-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  46 in total

1.  Developing effective chronic disease interventions in Africa: insights from Ghana and Cameroon.

Authors:  Ama de-Graft Aikins; Petra Boynton; Lem L Atanga
Journal:  Global Health       Date:  2010-04-19       Impact factor: 4.185

2.  Developed countries should be the focus for effectively reducing chronic disease.

Authors:  Eric J Buenz
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

Review 3.  How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Authors:  Leonardo M Fabbri; Cynthia Boyd; Piera Boschetto; Klaus F Rabe; A Sonia Buist; Barbara Yawn; Bruce Leff; David M Kent; Holger J Schünemann
Journal:  Proc Am Thorac Soc       Date:  2012-12

Review 4.  Curtailing the communicability of psychiatric disorders.

Authors:  Milton L Wainberg; Liat Helpman; Cristiane S Duarte; Sten H Vermund; Jennifer J Mootz; Lidia Gouveia; Maria A Oquendo; Karen McKinnon; Francine Cournos
Journal:  Lancet Psychiatry       Date:  2018-10-10       Impact factor: 27.083

Review 5.  Human behaviors determine health: strategic thoughts on the prevention of chronic non-communicable diseases in China.

Authors:  Zhi-Yin Yang; Zhen Yang; Lifang Zhu; Chengxuan Qiu
Journal:  Int J Behav Med       Date:  2011-12

6.  Mortality inequality among older adults in Mexico: the combined role of infectious and chronic disease.

Authors:  César González-González; Rafael Samper-Ternent; Rebeca Wong; Alberto Palloni
Journal:  Rev Panam Salud Publica       Date:  2014-02

7.  Short-term outcomes in heart failure patients with chronic obstructive pulmonary disease in the community.

Authors:  Noel O'Kelly; William Robertson; Jude Smith; Jonathan Dexter; Collette Carroll-Hawkins; Sudip Ghosh
Journal:  World J Cardiol       Date:  2012-03-26

8.  Community-based infant hearing screening for early detection of permanent hearing loss in Lagos, Nigeria: a cross-sectional study.

Authors:  B O Olusanya; S L Wirz; L M Luxon
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

9.  Tackling Africa's chronic disease burden: from the local to the global.

Authors:  Ama de-Graft Aikins; Nigel Unwin; Charles Agyemang; Pascale Allotey; Catherine Campbell; Daniel Arhinful
Journal:  Global Health       Date:  2010-04-19       Impact factor: 4.185

10.  The effect of different cardiovascular risk presentation formats on intentions, understanding and emotional affect: a randomised controlled trial using a web-based risk formatter (protocol).

Authors:  Cherry-Ann Waldron; John Gallacher; Trudy van der Weijden; Robert Newcombe; Glyn Elwyn
Journal:  BMC Med Inform Decis Mak       Date:  2010-07-30       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.